UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048059
Receipt number R000053994
Scientific Title Research on clinical characteristic of delayed sleep-wake phase disorder without delayed melatonin rhythm
Date of disclosure of the study information 2022/06/30
Last modified on 2023/04/26 19:58:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on clinical characteristic of delayed sleep-wake phase disorder without delayed melatonin rhythm

Acronym

Research on clinical characteristic of delayed sleep-wake phase disorder without delayed melatonin rhythm

Scientific Title

Research on clinical characteristic of delayed sleep-wake phase disorder without delayed melatonin rhythm

Scientific Title:Acronym

Research on clinical characteristic of delayed sleep-wake phase disorder without delayed melatonin rhythm

Region

Japan


Condition

Condition

circadian rhythm sleep-wake disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Elucidation of pathophysiology of circadian rhythm sleep-wake disorder(clinical characteristic)

Basic objectives2

Others

Basic objectives -Others

Elucidation of pathophysiology of circadian rhythm sleep-wake disorder(Homeostasis modulation)

Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Characteristics of patients without delayed melatonin rhythm

Key secondary outcomes

Association with comorbidities
Association with refractory


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

12 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

<Subjects> DSWPD or N24SWD patients
visiting sleep clinic in Fujita
Health University Hospital,
department of psychiatry
<Healthy person> age-and gendermatched
healthy people

<Subjects>
1. Patients who have received sufficient explanation and who have
given their written consent based
on their own free will
2. Patients who are 12 years old o
r older and graduated from elementary school at the time of consent
3. Patients diagnosed with DSWP
D or N24SWD based on ICSD-3
4.Whether or not there is a comorbidity of mental or physical illness
5.There are no particular restrictions on the current treatment

<Healthy person>
1.Those who have received sufficient explanation and who have given their written consent based on their own free will
2.Patients who are 12 years old or older and graduated from elementary school at the time of consent
3.Those without sleep-wake rhythm disturbance
4.Patients do not have sleep disorders or mental illness based on the diagnostic criteria of ICSD-3 or DSM-5

Key exclusion criteria

<Subjects>
1.Patients with strong suicidal ideation
2.Other patients who are judged
inappropriate by the principal
<Healthy person>
1. Patients with any sleep disorde
r or mental illness based on ICSD-
3 or DSM-5 diagnostic criteria
2.Patients using psychotropic dru
gs such as antipsychotics, antidep
ressants and sleeping pills
3. Other patients who are judged
inappropriate by the research dire
ctor or research director

Target sample size

80


Research contact person

Name of lead principal investigator

1st name TSUYOSHI
Middle name
Last name KITAJIMA

Organization

Fujita Health University

Division name

Department of Psychiatry

Zip code

4701192

Address

1-98 Dengakugakubo,Kutsukake-cho,Toyoake,Aichi,Japan

TEL

0562-93-2170

Email

tsuyoshi@fujita-hu.ac.jp


Public contact

Name of contact person

1st name MARINA
Middle name
Last name HIROSE

Organization

Fujita Health University

Division name

Department of Psychiatry

Zip code

4701192

Address

1-98 Dengakugakubo,Kutsukake-cho,Toyoake,Aichi,Japan

TEL

0562-93-2170

Homepage URL


Email

mhirose@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

Fujita Health University Research Grant

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

the ethics committee of Fujita Health University

Address

1-98 Dengakugakubo,Kutsukake-cho,Toyoake,Aichi,Japan

Tel

0562-93-2865

Email

f-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 06 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 09 Month 21 Day

Date of IRB

2022 Year 02 Month 21 Day

Anticipated trial start date

2022 Year 06 Month 07 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Electroencephalogram will be recorded
at home, and melatonin and cortisol in
saliva will be measured.


Management information

Registered date

2022 Year 06 Month 14 Day

Last modified on

2023 Year 04 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053994


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name